According to the CDC: Every three minutes and 11 seconds, someone dies of stroke. The medical device industry is answering the call in this country, developing new devices to help clear clots and speed patient recovery. Together with John Murray, Head of Global Strategic Marketing and Strategic Relationships at Johnson & Johnson MedTech Neurovascular, we'll talk with those pioneering neurosurgeons who are developing new procedures and setting higher expectations for new devices. We'll understand what drives them and learn how they view the future of this industry.
All content for Neuro Innovation Talks: J&J MedTech Neurovascular is the property of DeviceTalks Podcast Network and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
According to the CDC: Every three minutes and 11 seconds, someone dies of stroke. The medical device industry is answering the call in this country, developing new devices to help clear clots and speed patient recovery. Together with John Murray, Head of Global Strategic Marketing and Strategic Relationships at Johnson & Johnson MedTech Neurovascular, we'll talk with those pioneering neurosurgeons who are developing new procedures and setting higher expectations for new devices. We'll understand what drives them and learn how they view the future of this industry.
S1 E3 - J&J MedTech’s John Murray and Dr. Jacques Moret on early neurovascular innovation & mentorship
Neuro Innovation Talks: J&J MedTech Neurovascular
1 hour 5 minutes 4 seconds
11 months ago
S1 E3 - J&J MedTech’s John Murray and Dr. Jacques Moret on early neurovascular innovation & mentorship
In this episode of Neuro Innovation Talks, Host John Murray interviews Professor Jacques Moret, MD, Professor and Consultant Interventional Neuroradiology and Honorary Chairman, NEURI center, Bicetre University Hospital, a pioneer in neurovascular intervention, as he reflects on the early challenges and groundbreaking innovations that shaped the field.
Dr. Moret recounts the origins of balloon remodeling for brain aneurysm treatment, detailing the iterative process of developing this transformative technique and the critical role of collaboration with industry leaders. He highlights the technological and ethical considerations that informed his work, emphasizing the balance between innovation and patient safety.
The conversation delves into his philosophy of mentorship, the significance of anatomical knowledge in neurointervention, and the importance of maintaining humanity in patient care. Dr. Moret also discusses the future of neurovascular treatment, advocating for MRI-compatible devices and real-time functional imaging to enhance procedural outcomes.
Thank you to Confluent Medical Technologies for sponsoring this episode of Neuro Innovation Talks. To learn more about how Confluent Medical supports medical device companies, visit: www.confluentmedical.com.
Special thanks to the following, the Neuro Innovation Talks podcast series would not be possible without their support: Joanna Colangelo, Mark Dickinson, Whitney Garrett, Tracy Murray, SYK, Dr. Christophe Cognard, Dr. Laurent Spelle, and Dr. Vitor Pereira.
***
Enjoy this podcast? Follow Neuro Innovation Talks on all major podcast players: https://neuro-innovation-talks.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Neuro Innovation Talks: J&J MedTech Neurovascular
According to the CDC: Every three minutes and 11 seconds, someone dies of stroke. The medical device industry is answering the call in this country, developing new devices to help clear clots and speed patient recovery. Together with John Murray, Head of Global Strategic Marketing and Strategic Relationships at Johnson & Johnson MedTech Neurovascular, we'll talk with those pioneering neurosurgeons who are developing new procedures and setting higher expectations for new devices. We'll understand what drives them and learn how they view the future of this industry.
